Loading asset research
Q3 2026 earnings · Nov 5
InMed Pharmaceuticals Inc. Common Shares
INMNasdaq · USD · StocksQuote as of · Exchange session not verified$1.40
+1.45%
Today
INM
Loading 1D prices…
Market cap
$7.6M
Volume
39K
52w high
$2.5052w low
$0.575Company profile
InMed Pharmaceuticals Inc. Common Shares
InMed Pharmaceuticals Inc. operates as a pharmaceutical drug development company in the United States. The company researches and develops cannabinoid-based pharmaceuticals products. Its product candidates include INM-901 for Alzheimer's disease, INM-089 for dry age-related macular degeneration, and INM-755, a cannabinol cream. The company was formerly known as Cannabis Technologies Inc. and changed its name to InMed Pharmaceuticals Inc. in October 2014. InMed Pharmaceuticals Inc. was incorporated in 1981 and is based in Vancouver, Canada.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
VANCOUVER, United States
Employees
6
Fiscal year end
0630
CIK
1728328
Session & valuation
Open$1.39
Previous close$1.38
Day high$1.42
Day low$1.37
30-day avg. volume76.8K
Outstanding shares5.5M
Diluted EPS-$3.12
Latest annual period
P/E (trailing)-0.45
P/E (forward)-0.22
Price / book6.87
Beta0.98
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| CURXCuranex Pharmaceuticals Inc Common Stock | $7.6M | $0.00 | — | -$0.17 | +3.80% | Unrated |
| CNSPCNS Pharmaceuticals Inc. Common Stock | $7.6M | $0.00 | — | -$35.75 | 0.00% | Buy |
| SKYESkye Bioscience Inc. Common Stock | $7.5M | $0.00 | — | -$1.41 | -5.56% | Buy |
| IMNNImunon Inc. Common Stock | $7.7M | $0.00 | — | -$6.83 | -8.16% | Buy |
| LEXXLexaria Bioscience Corp. Common Stock | $7.2M | $20K | -25180.94% | -$0.21 | +3.86% | Buy |